Bruce S. Morra
Director/Board Member at BioPharm Solutions, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jeff Reich | M | 61 | 17 years | |
| Galina Temstin Krayz | M | - |
SoluBest Ltd.
 SoluBest Ltd. Pharmaceuticals: MajorHealth Technology SoluBest Ltd. develops proprietary nano-transport drug systems. Its products include fenofibrate, albendazole, resveratrol and testosterone undecanoate. The company was founded in 2001 and is headquartered in Ness Ziona, Isreal. | - |
| Sabina Glozman | M | - |
SoluBest Ltd.
SoluBest Ltd. Pharmaceuticals: MajorHealth Technology SoluBest Ltd. develops proprietary nano-transport drug systems. Its products include fenofibrate, albendazole, resveratrol and testosterone undecanoate. The company was founded in 2001 and is headquartered in Ness Ziona, Isreal. | - |
| Richard Miles | M | 81 |
Princeton University
| 52 years |
| Ronnie Hershmann | M | - |
SoluBest Ltd.
SoluBest Ltd. Pharmaceuticals: MajorHealth Technology SoluBest Ltd. develops proprietary nano-transport drug systems. Its products include fenofibrate, albendazole, resveratrol and testosterone undecanoate. The company was founded in 2001 and is headquartered in Ness Ziona, Isreal. | - |
| Rodney Kasan | M | - |
SoluBest Ltd.
SoluBest Ltd. Pharmaceuticals: MajorHealth Technology SoluBest Ltd. develops proprietary nano-transport drug systems. Its products include fenofibrate, albendazole, resveratrol and testosterone undecanoate. The company was founded in 2001 and is headquartered in Ness Ziona, Isreal. | - |
| Marcus Cohn | M | - |
SoluBest Ltd.
SoluBest Ltd. Pharmaceuticals: MajorHealth Technology SoluBest Ltd. develops proprietary nano-transport drug systems. Its products include fenofibrate, albendazole, resveratrol and testosterone undecanoate. The company was founded in 2001 and is headquartered in Ness Ziona, Isreal. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Stephen C. Ferruolo | M | - |
Princeton University
| 5 years |
| Andrea Baumann Lustig | F | - |
Princeton University
| 5 years |
| Francis H. Murphy | M | 85 |
Biopure Corp.
 Biopure Corp. Pharmaceuticals: MajorHealth Technology Biopure Corp. developed, manufactured and marketed oxygen therapeutics, a new class of pharmaceuticals that are administered intravenously to increase oxygen transport to the body's tissues. The company used patented and proprietary technology to develop and manufacture two products: Hemopure for human use, and Oxyglobin for veterinary use. It has developed Hemopure for the treatment of patients with cardiovascular ischemia. Oxyglobin, its veterinary product treated anemia in dogs, is the only oxygen therapeutic approved by the U.S. Food and Drug Administration and the European Commission. Biopure was founded in 1984 and was headquartered in Cambridge, MA. | 8 years |
| Paul A. Looney | M | 84 |
Biopure Corp.
Biopure Corp. Pharmaceuticals: MajorHealth Technology Biopure Corp. developed, manufactured and marketed oxygen therapeutics, a new class of pharmaceuticals that are administered intravenously to increase oxygen transport to the body's tissues. The company used patented and proprietary technology to develop and manufacture two products: Hemopure for human use, and Oxyglobin for veterinary use. It has developed Hemopure for the treatment of patients with cardiovascular ischemia. Oxyglobin, its veterinary product treated anemia in dogs, is the only oxygen therapeutic approved by the U.S. Food and Drug Administration and the European Commission. Biopure was founded in 1984 and was headquartered in Cambridge, MA. | 3 years |
| Louka T. Katseli | M | 72 |
Princeton University
| 4 years |
| Jane Kober | F | 80 |
Biopure Corp.
Biopure Corp. Pharmaceuticals: MajorHealth Technology Biopure Corp. developed, manufactured and marketed oxygen therapeutics, a new class of pharmaceuticals that are administered intravenously to increase oxygen transport to the body's tissues. The company used patented and proprietary technology to develop and manufacture two products: Hemopure for human use, and Oxyglobin for veterinary use. It has developed Hemopure for the treatment of patients with cardiovascular ischemia. Oxyglobin, its veterinary product treated anemia in dogs, is the only oxygen therapeutic approved by the U.S. Food and Drug Administration and the European Commission. Biopure was founded in 1984 and was headquartered in Cambridge, MA. | - |
| Kemal Dervis | M | 75 |
Princeton University
| 6 years |
| Arthouros Zervos | M | 71 |
Princeton University
| 5 years |
| Peter R. Sismondo | M | 67 |
Princeton University
| 4 years |
| John McIntire | M | - |
Princeton University
| 4 years |
| Henry Furlow Owsley | M | - |
Princeton University
| 4 years |
| Mary Cardosa | M | - |
Princeton University
| 4 years |
| W. Dillaway Ayres | M | 72 |
Princeton University
| 4 years |
| Rebecca M. Bergman | F | 66 |
Princeton University
| 4 years |
| John A. Shapiro | M | 72 |
Princeton University
| 4 years |
| Robert Hermann | M | - |
Princeton University
| 4 years |
| Thomas L. Corwin | M | - |
Princeton University
| 3 years |
| Binneg Y. Lao | M | - |
Princeton University
| 1 years |
| Paul D. Downs | M | - |
Princeton University
| 4 years |
| Cameron O. Smith | M | 73 |
Princeton University
| 4 years |
| James W. Lytle | M | - |
Princeton University
| 4 years |
| Carl F. Frischkorn | M | - |
Princeton University
| 4 years |
| Yang Sheng Liu | M | 74 |
Princeton University
| 4 years |
| Ranch C. Kimball | M | - |
Princeton University
| 4 years |
| Franklin Miller | M | - |
Princeton University
| 1 years |
| Kong Yam Tan | M | 68 |
Princeton University
| 4 years |
| Richard H. Currier | M | - |
Princeton University
| 4 years |
| David M. Abromowitz | M | - |
Princeton University
| 4 years |
| Trevor Grant Kilburn | M | - |
Princeton University
| 4 years |
| David Van Zandt | M | - |
Princeton University
| 4 years |
| Bob Brown | M | - |
Princeton University
| 4 years |
| Tom Blum | M | - |
Princeton University
| 4 years |
| Ethan Coen | M | 66 |
Princeton University
| 4 years |
| John Henry | M | - |
Princeton University
| 4 years |
| Jeffrey N. Gibbs | M | - |
Princeton University
| 4 years |
| Christopher Somers Moore | M | - |
Princeton University
| 4 years |
| Stephen Benson Kealhofer | M | - |
Princeton University
| 5 years |
| Jeffrey G. Grody | M | 68 |
Princeton University
| 4 years |
| Jim T. Kelsey | M | - |
Princeton University
| 4 years |
| Andrew E. Schultz | M | - |
Princeton University
| 4 years |
| Daniel M. Abuhoff | M | - |
Princeton University
| 4 years |
| Mark Linton | M | - |
Princeton University
| 4 years |
| Michael Kushma | M | - |
Princeton University
| 4 years |
| Lawrence Levinson | M | - |
Princeton University
| 4 years |
| Lorne Hill | M | - |
Princeton University
| 4 years |
| H. Remmel | M | 72 |
Princeton University
| 4 years |
| J. Blair Richardson | M | - |
Princeton University
| 4 years |
| John Hepburn | M | 75 |
Princeton University
| 4 years |
| Merrick Andlinger | M | - |
Princeton University
| 4 years |
| John Aristotle Phillips | M | - |
Princeton University
| 4 years |
| Pamela Daley | F | 71 |
Princeton University
| 4 years |
| Arthur Levinson | M | 73 |
Princeton University
| 3 years |
| Kneeland Youngblood | M | 69 |
Princeton University
| 4 years |
| Andrea Jung | F | 64 |
Princeton University
| 4 years |
| Jon Barfield | M | 72 |
Princeton University
| 4 years |
| David Franklin Sand | M | - |
Princeton University
| 4 years |
| Bennett Stewart | M | 71 |
Princeton University
| 4 years |
| Jonathan Javitt | M | 67 |
Princeton University
| 4 years |
| John Barry | M | 72 |
Princeton University
| 4 years |
| Marvin Slepian | M | 68 |
Princeton University
| 4 years |
| Ned J. Kelly | M | 70 |
Princeton University
| 5 years |
| Lynn A. Stout | F | 66 |
Princeton University
| 4 years |
| Mark Mealy | M | 66 |
Princeton University
| 4 years |
| James L. Shea | M | 70 |
Princeton University
| 4 years |
| Thomas Martin Connelly | M | 72 |
Princeton University
| 4 years |
| Peter R. Gates | M | - |
Princeton University
| 4 years |
| Christopher Forbes | M | 73 |
Princeton University
| 4 years |
| Meg Whitman | F | 66 |
Princeton University
| 4 years |
| Thomas Edelman | M | 73 |
Princeton University
| 4 years |
| Kevin M. Weiss | M | 66 |
Princeton University
| 4 years |
| Gregory Weaver | M | 68 | 2 years | |
| Michael Loughran | M | 66 |
Princeton University
| 4 years |
| R. Stillwell | M | 67 |
Princeton University
| 4 years |
| Yadin Kaufmann | M | - |
Princeton University
| 4 years |
| William Walton | M | 72 |
Princeton University
| 4 years |
| August Moretti | M | 73 |
Princeton University
| 4 years |
| John Anthony Allison | M | - |
Princeton University
| 3 years |
| Todd Hixon | M | - |
Princeton University
| 4 years |
| Charles F. Kireker | M | - |
Princeton University
| 4 years |
| David M. Robinson | M | 58 |
Princeton University
| 4 years |
| Scott Ungerer | M | 66 |
Princeton University
| 4 years |
| William T. Quicksilver | M | - |
Princeton University
| 4 years |
| Paul Edward von Kuster | M | 75 |
Princeton University
| 4 years |
| David G. Offensend | M | 69 |
Princeton University
| 4 years |
| Franklin Techar | M | - |
Princeton University
| 4 years |
| Glenn D. Engel | M | - |
Princeton University
| 4 years |
| Jerome Powell | M | - |
Princeton University
| 4 years |
| Eric Keith Scholl | M | 69 |
Princeton University
| 4 years |
| Kenneth Noonan | M | 76 |
Princeton University
| 3 years |
| Doug Greenwood | M | - |
Princeton University
| 4 years |
| Peter Kellogg | M | 67 |
Princeton University
| 4 years |
| William Lockhart Garwood | M | 67 |
Princeton University
| 4 years |
| Alan M. Spiro | M | - |
Princeton University
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 95 | 95.00% |
| Israel | 5 | 5.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Bruce S. Morra
- Personal Network
